Biomedical Engineering Reference
In-Depth Information
sulfate: implications for understanding troglitazone hepatotoxicity. Drug Metab Dispos
13(4):525-253.
135. Lu WJ, Tamai I, Nezu JI, Lai ML, Huang JD. 2006. Organic anion transporting
polypeptide-C mediates arsenic uptake in HEK-293 cells. J Biomed Sci 13(4):525-533.
136. Yamashiro W, Maeda K, Hirouchi M, Adachi Y, Hu Z, Sugiyama Y. 2006. Involvement of
transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist
of the angiotensin II AT1-receptor, in humans. Drug Metab Dispos 34(7):1247-1254.
137. Nakagomi-Hagihara R, Nakai D, Kawai K, Yoshigae Y, Tokui T, Abe T, Ikeda T. 2006.
OATP1B1, OATP1B3, and mrp2 are involved in hepatobiliary transport of olmesartan,
a novel angiotensin II blocker. Drug Metab Dispos 34(5):862-869.
138. Liu L, Cui Y, Chung AY, Shitara Y, Sugiyama Y, Keppler D, Pang KS. 2006. Vectorial
transport of enalapril by Oatp1a1/Mrp2 and OATP1B1 and OATP1B3/MRP2 in rat and
human livers. J Pharmacol Exp Ther 318(1):395-402.
139. Ismair MG, Stanca C, Ha HR, Renner EL, Meier PJ, Kullak-Ublick GA. 2003. Inter-
actions of glycyrrhizin with organic anion transporting polypeptides of rat and human
liver. Hepatol Res 26(4):343-347.
140. Smith NF, Acharya MR, Desai N, Figg WD, Sparreboom A. 2005. Identification of
OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel. Cancer Biol Ther
4(8):815-818.
141. Yamazaki M, Li B, Louie SW, Pudvah NT, Stocco R, Wong W, Abramovitz M, Demartis
A, Laufer R, Hochman JH, Prueksaritanont T, Lin JH. 2005. Effects of fibrates on
human organic anion-transporting polypeptide 1B1-, multidrug resistance protein 2-
and P-glycoprotein-mediated transport. Xenobiotica 35(7):737-753.
142. Vavricka SR, van Montfoort J, Ha HR, Meier PJ, Fattinger K. 2002. Interactions
of rifamycin SV and rifampicin with organic anion uptake systems of human liver.
Hepatology 36(1):164-172.
143. Wang X, Wolkoff AW, Morris ME. 2005. Flavonoids as a novel class of human organic
anion-transporting polypeptide OATP1B1 (OATP-C) modulators. Drug Metab Dispos
33(11):1666-1672.
144. Shimizu M, Fuse K, Okudaira K, Nishigaki R, Maeda K, Kusuhara H, Sugiyama Y. 2005.
Contribution of OATP (organic anion-transporting polypeptide) family transporters
to the hepatic uptake of fexofenadine in humans. Drug Metab Dispos 33(10):1477-
1481.
145. Maeda K, Kambara M, Tian Y, Hofmann AF, Sugiyama Y. 2006. Uptake of ur-
sodeoxycholate and its conjugates by human hepatocytes: role of Na( + )-taurocholate
cotransporting polypeptide (NTCP), organic anion transporting polypeptide (OATP)
1B1 (OATP-C), and oatp1B3 (OATP8). Mol Pharmacol 3(1):70-77.
146. Cui Y, K onig J, Keppler D. 2001. Vectorial transport by double-transfected cells
expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2.
Mol Pharmacol 60(5):934-943.
147. Ismair MG, Stieger B, Cattori V, Hagenbuch B, Fried M, Meier PJ, Kullak-Ublick
GA. 2001. Hepatic uptake of cholecystokinin octapeptide by organic anion-transporting
polypeptides OATP4 and OATP8 of rat and human liver. Gastroenterology 121(5):1185-
1190.
148. Chi Y, Khersonsky SM, Chang YT, Schuster VL. 2006. Identification of a new class of
prostaglandin transporter inhibitors and characterization of their biological effects on
prostaglandin E 2 transport. J Pharmacol Exp Ther 316(3):1346-1350.
 
Search WWH ::




Custom Search